Trials / Withdrawn
WithdrawnNCT00894101
Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation
A Phase II/III, Open Label, Non-Randomized, Multi-Center Study of Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation
- Status
- Withdrawn
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of California, Irvine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the clinical value of serial quantitative \[F-18\] FLT as a PET imaging tool in head and neck cancer patients clinically scheduled with radiation or radiation-chemotherapy combination in terms of safety and efficacy. Standard \[F-18\] FDG PET will be the active comparator.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [F-18] FLT | 10 mCi \[F-18\] FLT and 10 mCi \[F-18\] FDG will be used for PET imaging. |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2009-05-06
- Last updated
- 2018-07-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00894101. Inclusion in this directory is not an endorsement.